Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93766 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391028 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674512 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674893 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL1402291 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6130185 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| Glycylglycylglycine SCHEMBL98565 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6677616 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6120072 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL4586328 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025147774-A1 | COMPOSITIONS TARGETING BRADYKININ RECEPTOR B1 FOR MEDICAL IMAGING AND TREATMENT OF CANCER AND OTHER DISORDERS | ALPHA-9 ONCOLOGY INC. (CA) | 2025-07-17 | — | — | WO | claimed |
| CN-119300868-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20250000976-A1 | ANTI-BCMA SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-01-02 | — | — | US | claimed |
| CN-119053607-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2024-11-29 | — | — | CN | claimed |
| WO-2024193692-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | 映恩生物制药（苏州）有限公司 | 2024-09-26 | — | — | WO | claimed |
| CN-118684724-A | Linker and use thereof in ligand drug conjugates | 映恩生物制药（苏州）有限公司 | 2024-09-24 | — | — | CN | claimed |
| EP-4413043-A1 | ANTI-BCMA SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC CONSTRUCTS | National Research Council of Canada (CA) | 2024-08-14 | — | — | EP | claimed |
| US-20240066109-A1 | Klebsiella Pneumoniae O-Antigen Glycosylated Proteins and Methods of Making and Uses Thereof | VAXNEWMO LLC | 2024-02-29 | — | — | US | claimed |
| CN-117580593-A | Anthracycline antibody conjugates | 思进公司 | 2024-02-20 | — | — | CN | claimed |
| US-20240052013-A1 | SYSTEMS AND METHODS TO LINK CD40 SIGNALING TO ANTIGEN BINDING | FRED HUTCHINSON CANCER CENTER (US) | 2024-02-15 | — | — | US | claimed |
| EP-1615998-A2 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF Plant Science GmbH (DE) | 2006-01-18 | — | — | EP | claimed |
| WO-2004092349-A2 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2004-10-28 | — | — | WO | claimed |
| EP-1379658-A2 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2004-01-14 | — | — | EP | claimed |
| EP-1307479-A2 | HERBICIDE TARGET GENES AND METHODS | Syngenta Participations AG (CH) | 2003-05-07 | — | — | EP | claimed |
| WO-2001070980-A9 | ISOLATED G-PROTEIN COUPLED RECEPTORS, NUCLEIC ACID MOLECULES ENCODING GPCR PROTEINS, AND USES THEREOF AS INSECTICIDAL TARGETS | PE CORP NY (US) | 2003-01-16 | — | — | WO | claimed |
| WO-2002026246-A2 | PHARMACEUTICAL COMPOSITIONS COMPRISING POLYNUCLEOTIDES ENCODING A RAF PROTEIN | GSF-FORSCHUNGSZENTRUM FÜR UMWELT UND GESUNDHEIT, GMBH (DE) | 2002-04-04 | — | — | WO | claimed |
| WO-2002022821-A2 | ANTIMICROBIAL PEPTIDES AND METHODS OF USE | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2002-03-21 | — | — | WO | claimed |
| US-6355462-B1 | NUCLEOTIDE SEQUENCES CODING ENZYMATIC POLYPEPTIDE FOR USE IN THE GENERATION OF DISEASE RESISTANT PLANTS | E.I. DU PONT DE NEMOURS AND COMPANY | 2002-03-12 | — | — | US | claimed |
| WO-2002000696-A2 | HERBICIDE TARGET GENES AND METHODS | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-03 | — | — | WO | claimed |
| US-5717065-A | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-02-10 | — | — | US | claimed |